About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×

news

Company News Events Insights Webinars Virtual Tours

BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Manufacturing Facility

BioDuro-Sundia to acquire a fully-operational 45,000 ft2 commercial oral solid dose drug product manufacturing facility in Irvine, California | BioDuro-Sundia
August 23, 2021

BioDuro-Sundia Strengthens Leadership with New CFO and Operations SVP

SAN DIEGO and SHANGHAI, June 29, 2021 – BioDuro-Sundia, a leading drug discovery and development services organization backed by Advent International, announced today the appointment of two senior leadership positions: Nee Chuan Teo as Chief Financial Officer and Alice Lv, PhD as Senior Vice President of Operations. Both directly report to the global CEO. “The appointmen
June 29, 2021

BioDuro-Sundia’s China Analytical Lab Passes EU QP Audit

BioDuro-Sundia's Shanghai lab passes EU QP Audit, ensuring high-quality clinical product analytical services compliant with EMA, NMPA, and FDA standards.
April 23, 2021

BioDuro-Sundia Microbiology Laboratory Receives Quality Certification from Wuxi City CDC

The BSL-2 Microbiology Laboratory in BioDuro-Sundia’s Wuxi R&D Center passed a comprehensive on-site inspection from the Wuxi City Center for Disease ...
April 13, 2021

BioDuro-Sundia Services Support Tianjin Jun’an Bio Regulatory Approval for Diabetes Drug

BioDuro-Sundia facilitated Tianjin Jun’an Bio's NMPA approval for Gliclazide sustained release tablet, supporting its efficacy and quality as a generic diabetes
April 13, 2021
Total 85 12345678...1617
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all